BioCentury
ARTICLE | Company News

MGI sales and marketing update

May 2, 1994 7:00 AM UTC

MGI Pharma Inc. (MOGN) MOGN (Minneapolis) began sales of Salagen Tablets, which received FDA approval in March to treat radiation induced dry mouth in head and neck cancer. MOGN estimated the per day...